These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30191411)

  • 1. Ivabradine preserves dynamic sympathetic control of heart rate despite inducing significant bradycardia in rats.
    Kawada T; Shimizu S; Uemura K; Hayama Y; Yamamoto H; Shishido T; Nishikawa T; Sugimachi M
    J Physiol Sci; 2019 Mar; 69(2):211-222. PubMed ID: 30191411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ivabradine augments high-frequency dynamic gain of the heart rate response to low- and moderate-intensity vagal nerve stimulation under β-blockade.
    Kawada T; Yamamoto H; Uemura K; Hayama Y; Nishikawa T; Zheng C; Li M; Miyamoto T; Sugimachi M
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2201-H2210. PubMed ID: 33891515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous ivabradine augments the dynamic heart rate response to moderate vagal nerve stimulation in anesthetized rats.
    Kawada T; Yamamoto H; Uemura K; Hayama Y; Nishikawa T; Sugimachi M
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H597-H606. PubMed ID: 31298561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine does not acutely affect open-loop baroreflex static characteristics and spares sympathetic heart rate control in rats.
    Yamamoto H; Kawada T; Shimizu S; Uemura K; Inagaki M; Kakehi K; Iwanaga Y; Fukuda K; Miyamoto T; Miyazaki S; Sugimachi M
    Int J Cardiol; 2018 Apr; 257():255-261. PubMed ID: 29506704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.
    Heusser K; Tank J; Brinkmann J; Schroeder C; May M; Großhennig A; Wenzel D; Diedrich A; Sweep FC; Mehling H; Luft FC; Jordan J
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct inhibition, but indirect sensitization of pacemaker activity to sympathetic tone by the interaction of endotoxin with HCN-channels.
    Ebelt H; Geißler I; Ruccius S; Otto V; Hoffmann S; Korth H; Klöckner U; Zhang Y; Li Y; Grossmann C; Rueckschloss U; Gekle M; Stieber J; Frantz S; Werdan K; Müller-Werdan U; Loppnow H
    Clin Exp Pharmacol Physiol; 2015 Aug; 42(8):874-80. PubMed ID: 25933122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine restores tonic cardiovascular autonomic control and reduces tachycardia, hypertension and left ventricular inflammation in post-weaning protein malnourished rats.
    Guedes MR; de Noronha SISR; Chírico MTT; da Costa GDC; de Freitas Castro T; de Brito RCF; Vieira LG; Reis TO; Ribeiro MC; Reis AB; Carneiro CM; Bezerra FS; Montano N; da Silva VJD; de Menezes RCA; Chianca-Jr DA; Silva FCDS
    Life Sci; 2024 Jun; 346():122636. PubMed ID: 38614307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pacemaker current inhibition in experimental human cardiac sympathetic activation: a double-blind, randomized, crossover study.
    Schroeder C; Heusser K; Zoerner AA; Großhennig A; Wenzel D; May M; Sweep FC; Mehling H; Luft FC; Tank J; Jordan J
    Clin Pharmacol Ther; 2014 Jun; 95(6):601-7. PubMed ID: 24509430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine increases the high frequency gain ratio in the vagal heart rate transfer function via an interaction with muscarinic potassium channels.
    Kawada T; Yamamoto H; Miyamoto T; Hayama Y; Li M; Zheng C; Uemura K; Sugimachi M; Saku K
    Physiol Rep; 2021 Dec; 9(23):e15134. PubMed ID: 34889074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
    Wang J; Yang YM; Li Y; Zhu J; Lian H; Shao XH; Zhang H; Fu YC; Zhang LF
    J Cardiovasc Electrophysiol; 2019 Feb; 30(2):242-252. PubMed ID: 30302853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic accentuated antagonism of heart rate control during different levels of vagal nerve stimulation intensity in rats.
    Kawada T; Yokoi A; Nishiura A; Kakuuchi M; Yokota S; Matsushita H; Li M; Uemura K; Saku K
    Am J Physiol Regul Integr Comp Physiol; 2023 Feb; 324(2):R260-R270. PubMed ID: 36572552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locally injected ivabradine inhibits carrageenan-induced pain and inflammatory responses via hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.
    Miyake S; Higuchi H; Honda-Wakasugi Y; Fujimoto M; Kawai H; Nagatsuka H; Maeda S; Miyawaki T
    PLoS One; 2019; 14(5):e0217209. PubMed ID: 31125368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic effect of ivabradine against inflammatory pain mediated by hyperpolarization-activated cyclic nucleotide-gated cation channels expressed on primary afferent terminals in the spinal dorsal horn.
    Ohashi N; Uta D; Ohashi M; Baba H
    Pain; 2022 Jul; 163(7):1356-1369. PubMed ID: 35708467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of intravenous carvedilol versus metoprolol on baroreflex-mediated sympathetic circulatory regulation in rats.
    Yamamoto H; Kawada T; Shimizu S; Hayama Y; Shishido T; Iwanaga Y; Fukuda K; Miyazaki S; Sugimachi M
    Int J Cardiol; 2019 Jun; 285():65-71. PubMed ID: 30876665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.
    Chobanyan-Jürgens K; Heusser K; Duncker D; Veltmann C; May M; Mehling H; Luft FC; Schröder C; Jordan J; Tank J
    Sci Rep; 2018 May; 8(1):7748. PubMed ID: 29773827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
    Paterek A; Sochanowicz B; Oknińska M; Śmigielski W; Kruszewski M; Mackiewicz U; Mączewski M; Leszek P
    Biomed Pharmacother; 2021 Apr; 136():111250. PubMed ID: 33450487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on HCN Channels in the Heart: Function, Dysfunction and Pharmacology.
    Sartiani L; Romanelli MN; Mugelli A; Cerbai E
    Curr Drug Targets; 2015; 16(8):868-76. PubMed ID: 26028050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine and metoprolol differentially affect cardiac glucose metabolism despite similar heart rate reduction in a mouse model of dyslipidemia.
    Vaillant F; Lauzier B; Ruiz M; Shi Y; Lachance D; Rivard ME; Bolduc V; Thorin E; Tardif JC; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H991-H1003. PubMed ID: 27496881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Sympathetic Activity and Innervation With Chronic Ivabradine and β-Blocker Therapies: Analysis of Hypertensive Rats With Heart Failure.
    Kakehi K; Iwanaga Y; Watanabe H; Sonobe T; Akiyama T; Shimizu S; Yamamoto H; Miyazaki S
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):387-396. PubMed ID: 30786751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivabradine-Induced Bradycardia is Accompanied by Reduced Stress-Related Anxiety.
    Woodman R; Student J; Miller C; Lockette W
    Am J Hypertens; 2023 May; 36(6):316-323. PubMed ID: 36812223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.